On August 26, 2025, Predictive Oncology Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 543,544 shares of the company's common stock at a price of $0.76 per share, in a private placement. The total gross proceeds from the offering amounted to approximately $413,093.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Predictive Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-005680), on September 02, 2025, and is solely responsible for the information contained therein.